Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.

Autor:	Chitnis, Tanuja1 (AUTHOR) tchitnis@rics.bwh.harvard.edu, Banwell, Brenda2,3 (AUTHOR), Kappos, Ludwig4 (AUTHOR), Arnold, Douglas L5,6 (AUTHOR), Gücüyener, Kivilcim7 (AUTHOR), Deiva, Kumaran8 (AUTHOR), Skripchenko, Natalia9 (AUTHOR), Cui, Li-Ying10 (AUTHOR), Saubadu, Stephane11 (AUTHOR), Hu, Wenruo12 (AUTHOR), Benamor, Myriam11 (AUTHOR), Le-Halpere, Annaig11 (AUTHOR), Truffinet, Philippe11 (AUTHOR), Tardieu, Marc8 (AUTHOR), TERIKIDS Investigators (CORPORATE AUTHOR)
Zdroj:	Lancet Neurology. Dec2021, Vol. 20 Issue 12, p1001-1011. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu